About Josh Grass
Form D filings for NFlection Therapeutics from 2022 to 2023 list Josh Grass as director.
Josh Grass first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Josh Grass in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Josh Grass works with at each company, as listed on that company's latest Form D.
NFlection Therapeutics, Inc. · Form D, Jul 21, 2023
KP
Ketan Patel
Director
CP
Christopher Powala
Director
WH
William Hodder
President and Director
CG
Corey Goodman
Director